The future of new pure antiestrogens in clinical breast cancer Alan E. Wakeling 15th San Antonio Breast Cancer Symposium — Plenary lecture Pages: 1 - 9
Selenium and the risk of postmenopausal breast cancer in the DOM cohort P. A. H. van NoordM. J. MaasC. Collette Report Pages: 11 - 19
Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study P. G. KoendersL. V. A. M. BeexTh. J. Benraad Report Pages: 21 - 27
Comparative effect of embryonic mouse fibroblasts (Balb/c-3T3) on the proliferation of hormone-dependent (T-47D) and hormone-independent (MDA-MB-231) human breast cancer cell lines Gerard ChetriteLaurence DelalondeJorge R. Pasqualini Report Pages: 29 - 35
Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters Klaus H. BaumannLudwig KieselBenno Runnebaum Report Pages: 37 - 46
Progesterone receptors in routinely paraffin-embedded primary breast carcinomas and lymph node metastases E. Müller-HolznerA. G. ZeimetO. Dapunt Report Pages: 47 - 55
Toremifene and tamoxifen in advanced breast cancer - a double-blind cross-over trial Lars E. StenbygaardJørn HerrstedtPer Dombernowsky Report Pages: 57 - 63
Growth and metastasis of human breast carcinomas with Matrigel in athymic mice Rajeshwari R. MehtaJewell M. GravesTapas K. Gupta Report Pages: 65 - 71
Structural and functional studies of insulin receptors in human breast cancer Lucia FrittittaRiccardo VigneriVincenzo Trischitta Report Pages: 73 - 82
Toward a molecular understanding of human breast cancer: A hypothesis Jerry W. ShayWoodring E. WrightHarold Werbin Hypotheses Pages: 83 - 94